Literature DB >> 17652209

Accumulation of topical naproxen by cultured oral epithelium.

R R Fitzgerald1, J D Walters.   

Abstract

Topically administered non-steroidal anti-inflammatory drugs (NSAIDs) inhibit periodontal bone loss, but little is known about the mechanism by which they penetrate oral epithelium. Active transporters could potentially play a role in this process. In this study, we used a cell line derived from oral epithelium to investigate a role for transporters and to characterize conditions that enhance epithelial penetration. Using fluorescence to monitor uptake, we demonstrated that SCC-25 cell monolayers transport naproxen with a Michaelis constant (K(m)) and maximum velocity (V(max)) of 164 microg/mL and 0.94 ng/min/microg protein, respectively. At steady state, the intra-cellular/extracellular concentration ratio was 3.4. Naproxen accumulation was more efficient at acidic pH than under neutral or alkaline conditions. Small proportions of glycerol, Pluronic F-127, and glucosylceramide enhanced naproxen entry. The individual and combined effects of glycerol and Pluronic F-127 were of lesser magnitude than those obtained with glucosylceramide or at pH 6.3. Thus, SCC-25 cells possess transporters for naproxen.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652209      PMCID: PMC2279179          DOI: 10.1177/154405910708600817

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  29 in total

1.  Accumulation of non-steroidal anti-inflammatory drugs by gingival fibroblasts.

Authors:  M M Zavarella; O Gbemi; J D Walters
Journal:  J Dent Res       Date:  2006-05       Impact factor: 6.116

Review 2.  Host response modulation in the management of periodontal diseases.

Authors:  Giovanni E Salvi; Niklaus P Lang
Journal:  J Clin Periodontol       Date:  2005       Impact factor: 8.728

3.  Increased susceptibility of ethanol-treated gastric mucosa to naproxen and its inhibition by DA-9601, an Artemisia asiatica extract.

Authors:  Tae Young Oh; Gook Jun Ahn; Seul Min Choi; Byoung Ok Ahn; Won Bae Kim
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

4.  An in vitro model of ciprofloxacin and minocycline transport by oral epithelial cells.

Authors:  James J Brayton; Qing Yang; Robin J Nakkula; John D Walters
Journal:  J Periodontol       Date:  2002-11       Impact factor: 6.993

Review 5.  Sphingolipids in food and the emerging importance of sphingolipids to nutrition.

Authors:  H Vesper; E M Schmelz; M N Nikolova-Karakashian; D L Dillehay; D V Lynch; A H Merrill
Journal:  J Nutr       Date:  1999-07       Impact factor: 4.798

6.  An accumulation of glucosylceramide in the stratum corneum due to attenuated activity of beta-glucocerebrosidase is associated with the early phase of UVB-induced alteration in cutaneous barrier function.

Authors:  Yutaka Takagi; Hidemi Nakagawa; Toshiaki Yaginuma; Yoshinori Takema; Genji Imokawa
Journal:  Arch Dermatol Res       Date:  2005-05-24       Impact factor: 3.017

Review 7.  Role of ceramides in barrier function of healthy and diseased skin.

Authors:  Myeong Jun Choi; Howard I Maibach
Journal:  Am J Clin Dermatol       Date:  2005       Impact factor: 7.403

8.  Effects of ketorolac tromethamine mouthrinse (0.1%) on crevicular fluid prostaglandin E2 concentrations in untreated chronic periodontitis.

Authors:  P M Preshaw; B Lauffart; P Brown; E Zak; P A Heasman
Journal:  J Periodontol       Date:  1998-07       Impact factor: 6.993

9.  Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane.

Authors:  Daisuke Kobayashi; Takashi Nozawa; Kozue Imai; Jun-ichi Nezu; Akira Tsuji; Ikumi Tamai
Journal:  J Pharmacol Exp Ther       Date:  2003-04-30       Impact factor: 4.030

10.  Synthetic ceramide analogues as skin permeation enhancers: structure-activity relationships.

Authors:  Katerina Vávrová; Alexandr Hrabálek; Pavel Dolezal; Lucie Sámalová; Karel Palát; Jarmila Zbytovská; Tomás Holas; Jana Klimentová
Journal:  Bioorg Med Chem       Date:  2003-12-01       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.